Sentence examples for markers for outcome from inspiring English sources

Markers for outcome prediction in bladder cancer are urgently needed.

Whether early laboratory findings could serve as prognostic markers for outcome was explored.

However, more detailed and accurate information regarding its pathological features, biological markers for outcome, and potential therapeutic targets is warranted to improve follow-up and develop treatment strategies for patients with UC-UUT.

DNA methylation of a selected panel of genes represents another potential set of markers for outcome prediction that are less dependent on scrupulous handling of the biopsy after resection [ 29] and remain stable even in formalin-fixed, paraffin-embedded material.

Thus, based on response rates and depth of response as surrogate markers for outcome, VRd is commonly included in myeloma treatment guidelines as one of several preferred options for initial therapy for transplant-eligible as well as for transplant-ineligible patients in the United States.

In addition to pharmacogenetic markers for outcome following specific drug treatment, there are a variety of patient characteristics (e.g. lymph node metastases, age), histologic findings (e.g. neurovascular invasion, differentiation), and genetic factors (e.g. p53 expression, microsatellite instability), which appear to influence patient prognosis in colorectal cancer.

We welcome bold moves by the FDA to incorporate new technologies into the regulatory process, including the expanded use of accelerated approvals, and the use of new surrogate markers for outcomes.

To elucidate if the density of inflammatory cells expressing S100A9 in malignant and surrounding non-malignant prostate tissues is a prognostic marker for outcome in prostate cancer patients.

In view of the similar results of the NASCET and ECST trials, this suggests that degree of stenosis may only be a surrogate marker for outcome following carotid endarterectomy.

To date, no reliable predictive marker for outcome after CA exists.

In contrast, other research suggested that mHLA-DR was not a useful prognostic marker for outcome.